News ESC: Study says GLP-1s treat heart failure AND cut emissions Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines.
News UK approves AZ inhaler with 'greener' propellant AstraZeneca has its first regulatory approval for an inhaler product using a propellant with a massively reduced global warming potential.
News GSK says new inhaler will help slash its carbon footprint GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly hal
Healthcare Bring point of care testing to the community for a preventat... The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new
Sustainability Life sciences faces a battle with sustainability, but let’s ... We know that the global healthcare sector is a contributor to the warming of our planet.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
